TY - JOUR KW - Clofazimine KW - Dapsone KW - Diagnosis, Differential KW - Drug Therapy, Combination KW - Humans KW - Leprostatic Agents KW - leprosy KW - Mycobacterium leprae KW - Peripheral Nervous System Diseases KW - Rifampin AU - Marlowe S N AU - Lockwood DN AB -

Leprosy, a result of infection by Mycobacterium leprae, is a leading cause of peripheral neuropathy. The World Health Organization aimed to eliminate leprosy as a public health problem by 2000, but this has not been attained. Patients with leprosy continue to present in the UK. The diagnosis of leprosy is frequently not considered, with resultant pathological and psychological problems for patients.

BT - Hospital medicine (London, England : 1998) C1 - http://www.ncbi.nlm.nih.gov/pubmed/11530584?dopt=Abstract CN - MARLOWE 2001 DA - 2001 Aug DO - 10.12968/hosp.2001.62.8.1622 IS - 8 J2 - Hosp Med LA - eng N2 -

Leprosy, a result of infection by Mycobacterium leprae, is a leading cause of peripheral neuropathy. The World Health Organization aimed to eliminate leprosy as a public health problem by 2000, but this has not been attained. Patients with leprosy continue to present in the UK. The diagnosis of leprosy is frequently not considered, with resultant pathological and psychological problems for patients.

PY - 2001 SP - 471 EP - 6 T2 - Hospital medicine (London, England : 1998) TI - Update on leprosy. VL - 62 SN - 1462-3935 ER -